基石药业-B：谢芳已获委任为独立非执行董事

Core Viewpoint - 基石药业-B (02616) announces the appointment of Xie Fang as an independent non-executive director and chair of the audit committee, as well as a member of the remuneration committee, nomination committee, and investment committee, effective from November 1, 2025 [1] Group 1 - He Ye resigns from the position of independent non-executive director, chair of the audit committee, and member of the remuneration committee, nomination committee, strategic committee, and investment committee, effective at the end of business on October 31, 2025 [1]